<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2025-11-3-1-0</article-id><article-id pub-id-type="publisher-id">3856</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine (miscellaneous)</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Features of the gut microbiome in people with increased anxiety&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Features of the gut microbiome in people with increased anxiety&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Novokovich</surname><given-names>Yulia S.</given-names></name><name xml:lang="en"><surname>Novokovich</surname><given-names>Yulia S.</given-names></name></name-alternatives><email>novokovich@inbox.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Glotov</surname><given-names>Oleg S.</given-names></name><name xml:lang="en"><surname>Glotov</surname><given-names>Oleg S.</given-names></name></name-alternatives><email>olglotov@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Danilov</surname><given-names>Lavrentii G.</given-names></name><name xml:lang="en"><surname>Danilov</surname><given-names>Lavrentii G.</given-names></name></name-alternatives><email>l.danilov@spbu.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Sevastenkova</surname><given-names>Marina S.</given-names></name><name xml:lang="en"><surname>Sevastenkova</surname><given-names>Marina S.</given-names></name></name-alternatives><email>marisvs123@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Dudurich</surname><given-names>Vasilisa V.</given-names></name><name xml:lang="en"><surname>Dudurich</surname><given-names>Vasilisa V.</given-names></name></name-alternatives><email>vasilisadudurich@yandex.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Kusakin</surname><given-names>Alexey V.</given-names></name><name xml:lang="en"><surname>Kusakin</surname><given-names>Alexey V.</given-names></name></name-alternatives><email>kusakinax@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Ermachenko</surname><given-names>Ekaterina D.</given-names></name><name xml:lang="en"><surname>Ermachenko</surname><given-names>Ekaterina D.</given-names></name></name-alternatives><email>eyermachenko@cerbalab.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Glotov</surname><given-names>Andrey S.</given-names></name><name xml:lang="en"><surname>Glotov</surname><given-names>Andrey S.</given-names></name></name-alternatives><email>anglotov@mail.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2025</year></pub-date><volume>11</volume><issue>3</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2025/3/Биомедисследования_3-180-197.pdf" /><abstract xml:lang="ru"><p>Background: Anxiety and anxiety disorders are among the most common mental illnesses worldwide. There is increasing evidence that the gut microbiome plays a role in the development of mental disorders. It has been established that the human intestine contains the second largest concentration of neurons after the brain, and it is connected to it by a bidirectional &amp;laquo;microbiome-gut-brain communication axis&amp;raquo;. The aim of the study: To conduct a comparative assessment of the composition of the intestinal microbiota between a group of people who noted the presence of increased anxiety, as indicated by a high Spielberger-Hanin test score, with a group of people who did not note the presence of increased anxiety, with a low or moderate score, as indicated by a Spielberger-Hanin test score, living in the European part of Russia, followed by the construction of a prognostic model of such risk. Materials and methods: The study involved 28 men (average age 37.5 years) and 91 women (average age 38 years). The Spielberger-Hanin test and a general patient questionnaire were used to assess the level of anxiety. The experimental group under study consisted of 49 people, while the control group consisted of 70. The identification of the taxonomic composition of the intestinal microbiota was carried out by sequencing bacterial 16S rRNA genes followed by bioinformatic analysis. Statistical processing of the study results was carried out using linear discriminant (LEfSe) analysis and the Wilcoxon criterion. To build a predictive model, the linear regression method was used with the calculation of the AuRoc indicator. Results: We obtained significant differences between the experimental and control groups at the level of types, classes and genera of bacteria. In the experimental group, Actinobacteriota (p=0.008), Actinobacteria (p=0.014), Bifidobacterium (p=0.011), Subdoligranulum (p=0.031), Lachnospira (p=0.008), CAG_873 (p=0.014), Roseburia (p=0.019), Lactonifactor (p=0.02), Erisibelotrichacee UGG_003 (p=0.002), Eggerthella (p=0.021) were increased, and Lactobacillus (p=0.030), Rothia (p=0.047), Caprociproducens (p=0.030), Desulfovibrio (p=0.041), Caprobacter (p=0.037) were decreased. The calculated indicator of the AuRoc predictive model was 0.755. Conclusion: The use of the 16S rRNA gene sequencing method makes it possible to identify the features of the microbiome in people with increased anxiety. The data obtained can be useful for understanding the mechanisms of development and correction of these conditions, and the presence of certain bacterial taxa can be used as markers in predicting anxiety</p></abstract><trans-abstract xml:lang="en"><p>Background: Anxiety and anxiety disorders are among the most common mental illnesses worldwide. There is increasing evidence that the gut microbiome plays a role in the development of mental disorders. It has been established that the human intestine contains the second largest concentration of neurons after the brain, and it is connected to it by a bidirectional &amp;laquo;microbiome-gut-brain communication axis&amp;raquo;. The aim of the study: To conduct a comparative assessment of the composition of the intestinal microbiota between a group of people who noted the presence of increased anxiety, as indicated by a high Spielberger-Hanin test score, with a group of people who did not note the presence of increased anxiety, with a low or moderate score, as indicated by a Spielberger-Hanin test score, living in the European part of Russia, followed by the construction of a prognostic model of such risk. Materials and methods: The study involved 28 men (average age 37.5 years) and 91 women (average age 38 years). The Spielberger-Hanin test and a general patient questionnaire were used to assess the level of anxiety. The experimental group under study consisted of 49 people, while the control group consisted of 70. The identification of the taxonomic composition of the intestinal microbiota was carried out by sequencing bacterial 16S rRNA genes followed by bioinformatic analysis. Statistical processing of the study results was carried out using linear discriminant (LEfSe) analysis and the Wilcoxon criterion. To build a predictive model, the linear regression method was used with the calculation of the AuRoc indicator. Results: We obtained significant differences between the experimental and control groups at the level of types, classes and genera of bacteria. In the experimental group, Actinobacteriota (p=0.008), Actinobacteria (p=0.014), Bifidobacterium (p=0.011), Subdoligranulum (p=0.031), Lachnospira (p=0.008), CAG_873 (p=0.014), Roseburia (p=0.019), Lactonifactor (p=0.02), Erisibelotrichacee UGG_003 (p=0.002), Eggerthella (p=0.021) were increased, and Lactobacillus (p=0.030), Rothia (p=0.047), Caprociproducens (p=0.030), Desulfovibrio (p=0.041), Caprobacter (p=0.037) were decreased. The calculated indicator of the AuRoc predictive model was 0.755. Conclusion: The use of the 16S rRNA gene sequencing method makes it possible to identify the features of the microbiome in people with increased anxiety. The data obtained can be useful for understanding the mechanisms of development and correction of these conditions, and the presence of certain bacterial taxa can be used as markers in predicting anxiety</p></trans-abstract><kwd-group xml:lang="ru"><kwd>personal anxiety</kwd><kwd>anxiety</kwd><kwd>microbiome</kwd><kwd>gut microbiome</kwd><kwd>16S rRNA sequencing</kwd><kwd>bifidobacteria</kwd><kwd>lactobacilli</kwd></kwd-group><kwd-group xml:lang="en"><kwd>personal anxiety</kwd><kwd>anxiety</kwd><kwd>microbiome</kwd><kwd>gut microbiome</kwd><kwd>16S rRNA sequencing</kwd><kwd>bifidobacteria</kwd><kwd>lactobacilli</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Merkin AG, Akinfieva SS, Martyushev-Poklad AV, et al. Anxiety: phenomenology, epidemiology, and risk factors during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):107-112. DOI: https://doi.org/&amp;nbsp;10.14412/2074-2711-2021-1-107-112</mixed-citation></ref><ref id="B2"><mixed-citation>World Health Organization. WHO director-general&amp;rsquo;s opening remarks at the mental health at work panel - World Economic Forum - 18 January 2023 [Internet] [cited 2024 Aug 13]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-mental-health-at-work-panel--world-economic-forum---18-january-2023</mixed-citation></ref><ref id="B3"><mixed-citation>Pomytkina TE, Butorina EV, Nedoseev SS, et al. The relationship of personal anxiety with the development of psychosomatic diseases. In: Proceedings of the GNII &amp;quot;National Development&amp;quot;; St. Petersburg, June 26-30, 2021. St. Petersburg: GNII &amp;quot;National Development&amp;quot;; 2021.</mixed-citation></ref><ref id="B4"><mixed-citation>Shamgunova KM, Afanasyeva AI. Psychophysiological aspects of anxiety. Psychology of development and education 2023;1:58-60. Russian.</mixed-citation></ref><ref id="B5"><mixed-citation>Petelin DS, Sorokina OY, Troshina DV, et al. Anxiety disorders in general medical practice &amp;ndash; clinical picture, diagnosis, optimized approaches to therapy. Medical Council. 2023;3:110-118. Russian. DOI: https://doi.org/10.21518/ms2023-053</mixed-citation></ref><ref id="B6"><mixed-citation>Petrova NN, Palkin YuR, Faddeev DV, et al. Comorbidity of depression and anxiety in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4):31‑37. Russian. DOI: https://doi.org/10.17116/jnevro202112104131</mixed-citation></ref><ref id="B7"><mixed-citation>Zemskov AM, Bakuleva NI, Shiryayev OYu, et al. Modern Ideas of Neurochemical, Immunological and Genetic Aspects of Anxiety and Depression (Literature Review). Science of the young (Eruditio&amp;nbsp; Juvenium). 2023;11(4):581-593. Russian. DOI: https://doi.org/HMJ2023114581-593</mixed-citation></ref><ref id="B8"><mixed-citation>Kotova OV, Belyaev AA, Akarachkova EU. Modern methods of diagnosis and treatment of anxiety and depressive disorders. Russian Medical Journal. 2021;5(10):648-653. Russian. DOI: https://doi.org/10.32364/2587-6821-2021-5-10-648-653</mixed-citation></ref><ref id="B9"><mixed-citation>Tallerova AV, Ryabov SV. Microbiome imbalance and its significance for the functioning of the gut-brain axis: an analysis of mental health problems. In: Popova AY, Zaitseva NV, et al. editors. Health Risk Analysis &amp;ndash; 2024. Proceedings of the XIV All-Russian scientific-practical conference with international participation. Perm: PNIPU; 2024. Russian.</mixed-citation></ref><ref id="B10"><mixed-citation>G&amp;oacute;ralczyk-Bińkowska A, Szmajda-Krygier D, Kozłowska E. The microbiota-gut-brain axis in psychiatric disorders. International Journal of Molecular Sciences. 2022;23(19):11245. DOI: https://doi.org/10.3390/ijms231911245</mixed-citation></ref><ref id="B11"><mixed-citation>Kharitonova LA, Grigoriev KI, Borzakova SN. Human microbiote: how a new scientifi c paradigm changes medical practice. Experimental and Clinical Gastroenterology. 2019;1(161):55-63. Russian. DOI: https://doi.org/10.31146/1682-8658-ecg-161-1-55-63</mixed-citation></ref><ref id="B12"><mixed-citation>Shulpekova YuO. The intestinal microbiome as a separate organ. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014;24(6):82-88. Russian.</mixed-citation></ref><ref id="B13"><mixed-citation>Konjevod M, Nikolac-Perkovic M, S&amp;aacute;iz J, et al. Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases. Journal of Pharmaceutical and Biomedical Analysis. 2021;194:113681. DOI: https://doi.org/10.1016/j.jpba.2020.113681</mixed-citation></ref><ref id="B14"><mixed-citation>Hou K, Wu ZX, Chen XY, et al. Microbiota in health and diseases. Signal Transduction and Targeted Therapy. 2022;7(1):135. DOI: https://doi.org/10.1038/s41392-022-00974-4</mixed-citation></ref><ref id="B15"><mixed-citation>Nikolova VL, Smith MRB, Hall LJ, et al. Perturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis. JAMA Psychiatry. 2021;78(12):1343-1354. DOI:&amp;nbsp;https://doi.org/10.1001/jamapsychiatry.2021.2573</mixed-citation></ref><ref id="B16"><mixed-citation>Ritchie G, Strodl E, Parham S, et al. An exploratory study of the gut microbiota in major depression with anxious distress. Journal of Affective Disorders. 2023;320:595-604. DOI:&amp;nbsp;https://doi.org/10.1016/j.jad.2022.10.001</mixed-citation></ref><ref id="B17"><mixed-citation>Mason BL, Li Q, Minhajuddin A, et al. Reduced anti-inflammatory gut microbiota are associated with depression and anhedonia. Journal of Affective Disorders. 2020;266:394-401. DOI: https://doi.org/10.1016/j.jad.2020.01.137</mixed-citation></ref><ref id="B18"><mixed-citation>Zhu J, Li M, Shao D, et al. Altered fecal microbiota signatures in patients with anxiety and depression in the gastrointestinal cancer screening: A case-control study. Frontiers in Psychiatry. 2021;12:1832. DOI:&amp;nbsp;https://doi.org/10.3389/fpsyt.2021.757139</mixed-citation></ref><ref id="B19"><mixed-citation>Chen JJ, He S, Fang L, et al. Age-specific differential changes on gut microbiota composition in patients with major depressive disorder. Aging. 2020;12(3):2764-2776. DOI:&amp;nbsp;https://doi.org/10.18632/aging.102775</mixed-citation></ref><ref id="B20"><mixed-citation>Mallott EK, Sitarik AR, Leve LD, et al. Human microbiome variation associated with race and ethnicity emerges as early as 3 months of age. PLoS Biology. 2023;21(8):e3002230. DOI: https://doi.org/10.1371/journal.pbio.3002230</mixed-citation></ref><ref id="B21"><mixed-citation>Khanin YuL. A brief guide to the use of the C. D. Spielberger scale of reactive and personal anxiety. St. Petersburg; 2002. Russian.</mixed-citation></ref><ref id="B22"><mixed-citation>Singh P, Teal TK, Marsh TL, et al. Intestinal microbial communities associated with acute enteric infections and disease recovery. Microbiome. 2015;3:45. DOI: https://doi.org/10.1186/s40168-015-0109-2</mixed-citation></ref><ref id="B23"><mixed-citation>Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nature Biotechnology. 2019;37:852-857. DOI:&amp;nbsp;https://doi.org/10.1038/s41587-019-0209-9</mixed-citation></ref><ref id="B24"><mixed-citation>Pichler M, Coskun &amp;Ouml;K, Ortega-Arbul&amp;uacute; AS, et al. A 16S rRNA gene sequencing and analysis protocol for the Illumina MiniSeq platform. MicrobiologyOpen. 2018;7(6):611. DOI:&amp;nbsp;https://doi.org/10.1002/mbo3.611</mixed-citation></ref><ref id="B25"><mixed-citation>Zhong Q, Chen JJ, Wang Y, et al. Differential gut microbiota compositions related with the severity of major depressive disorder. Frontiers in Cellular and Infection Microbiology. 2022;12:907239. DOI:&amp;nbsp;https://doi.org/10.3389/fcimb.2022.907239</mixed-citation></ref><ref id="B26"><mixed-citation>Barandouzi ZA, Starkweather AR, Henderson WA, et al. Altered composition of gut microbiota in depression: A systematic review. Frontiers in Psychiatry. 2020;11:541. DOI:&amp;nbsp;https://doi.org/10.3389/fpsyt.2020.00541</mixed-citation></ref><ref id="B27"><mixed-citation>Duranti S, Ruiz L, Lugli GA, et al. Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA. Scientific Reports. 2020;10:14112. DOI:&amp;nbsp;https://doi.org/10.1038/s41598-020-70986-z</mixed-citation></ref><ref id="B28"><mixed-citation>Duman RS, Sanacora G, Krystal JH, et al. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron. 2019;102(1):75-90. DOI: https://doi.org/10.1016/j.neuron.2019.03.013</mixed-citation></ref><ref id="B29"><mixed-citation>Radjabzadeh D, Bosch JA, Uitterlinden AG, et al. Gut microbiome-wide association study of depressive symptoms. Nature Communications. 2022;13:7128. DOI: https://doi.org/10.1038/s41467-022-34502-3</mixed-citation></ref><ref id="B30"><mixed-citation>Cheung SG, Goldenthal AR, Uhlemann AC, et al. Systematic review of gut microbiota and major depression. Frontiers in Psychiatry. 2019;10:34. DOI: https://doi.org/10.3389/fpsyt.2019.00034</mixed-citation></ref><ref id="B31"><mixed-citation>Yuan X, Chen B, Duan Z, et al. Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics. Gut Microbes. 2021;13(1):1987779. DOI: https://doi.org/10.1080/19490976.2021.1987779</mixed-citation></ref><ref id="B32"><mixed-citation>Zhou M, Fan Y, Xu L, et al. Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice. Microbiome. 2023;11(1):145. DOI: https://doi.org/10.1186/s40168-023-01589-9</mixed-citation></ref><ref id="B33"><mixed-citation>Thompson DS, Fu C, Gandhi T, et al. Differential co-expression networks of the gut microbiota are associated with depression and anxiety treatment resistance among psychiatric inpatients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2023;120:110638. DOI:&amp;nbsp;https://doi.org/10.1016/j.pnpbp.2022.110638</mixed-citation></ref><ref id="B34"><mixed-citation>Lai WT, Deng WF, Xu SX, et al. Shotgun metagenomics reveals both taxonomic and tryptophan pathway differences of gut microbiota in major depressive disorder patients. Psychological Medicine. 2021;51(1):90-101. DOI:&amp;nbsp;https://doi.org/10.1017/S0033291719003027</mixed-citation></ref><ref id="B35"><mixed-citation>Ho YT, Tsai YC, Kuo TB, et al. Effects of Lactobacillus plantarum PS128 on depressive symptoms and sleep quality in self-reported insomniacs: A randomized, double-blind, placebo-controlled pilot trial. Nutrients. 2021;13(8):2820. DOI: https://doi.org/10.3390/nu13082820</mixed-citation></ref><ref id="B36"><mixed-citation>Zhu J, Li M, Shao D, et al. Altered fecal microbiota signatures in patients with anxiety and depression in the gastrointestinal cancer screening: A case-control study. Frontiers in Psychiatry. 2021;12:1832. DOI:&amp;nbsp;https://doi.org/10.3389/fpsyt.2021.757139</mixed-citation></ref><ref id="B37"><mixed-citation>Knudsen JK, Bundgaard-Nielsen C, Leutscher P, et al. Differences in bacterial taxa between treatment-naive patients with major depressive disorder and non-affected controls may be related to a proinflammatory profile. BMC Psychiatry. 2024;24(1):84. DOI: https://doi.org/10.1186/s12888-024-05547-z</mixed-citation></ref><ref id="B38"><mixed-citation>Murros KE, Huynh VA, Takala TM, et al. Desulfovibrio bacteria are associated with Parkinson&amp;#39;s disease. Frontiers in Cellular and Infection Microbiology. 2021;11:652617. DOI:&amp;nbsp;https://doi.org/10.3389/fcimb.2021.652617</mixed-citation></ref><ref id="B39"><mixed-citation>Humbel F, Rieder JH, Franc Y, et al. Association of alterations in intestinal microbiota with impaired psychological function in patients with inflammatory bowel diseases in remission. Clinical Gastroenterology and Hepatology. 2020;18:2019-2029 DOI: https://doi.org/10.1016/j.cgh.2019.12.021</mixed-citation></ref><ref id="B40"><mixed-citation>Gonzalez-Mercado VJ, Lim J, Saligan LN, et al. Gut microbiota and depressive symptoms at the end of CRT for rectal cancer: A cross-sectional pilot study. Depression Research and Treatments. 2021;2021:7967552. DOI: https://doi.org/10.1155/2021/7967552</mixed-citation></ref></ref-list></back></article>